No Data
No Data
H.C. Wainwright Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4
Express News | Vivani Medical Inc - Financial Terms of Expanded Agreement Not Disclosed
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
Express News | EXCLUSIVE: Vivani Medical Tells Benzinga 'Over Half of All Dogs in the United States Today Are Overweight or Obese, Placing Them at Increased Risk for Chronic Diseases, Metabolic Decline and Shortened Lifespans'
Express News | EXCLUSIVE: Vivani Medical Tells Benzinga Co. And Okava Expand Collaboration To Develop OKV-119 For Dogs, Targeting Metabolic Health And Longevity
Insider Buying: Vivani Medical Independent Chairman of the Board Bought US$205k Of Shares